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Background
We reported an atypical cohort of antiretroviral-treated
patients who developed or had unremitting Kaposi’s sar-
coma (KS) despite having undetectable viral loads and
high CD4 cell counts. The KS course of these patients is
indolent, resembling elderly or classical HIV- KS. Since
HIV infection is associated with accelerated immunolo-
gic aging (“immunosenescence”), and since classical
HIV- KS of the elderly may be related to age-associated
T cell dysfunction, we hypothesized that T cell immuno-
senescence would be associated with the presence of
this atypical KS.
Materials and methods
We identified 19 individuals on antiretroviral therapy
(ART) who developed or had unremitting KS after an
interval of at least 24 months with viral loads <75 copies
RNA/mL and peripheral CD4 cell counts >300 cells/
mm
3. We also recruited 47 HIV+ KS- controls on ART
with viral loads <75 copies RNA/mL and peripheral
CD4 cell counts >300 cells/mm
3. Global immunosenes-
cence markers CD28 and CD57, as well as naïve cell
phenotypic coexpression of CD27+/CD28+/CD45RA+,
were examined in peripheral blood via flow cytometry.
Results
All cases and controls were men. Cases and controls were
not significantly different with regard to CD4 or CD8 cell
count and viral load, though age was significantly differ-
ent (p<0.001, Table 1). Cases had a higher proportion of
CD57+CD8+ T cells vs. controls (median of 41.5% vs.
27.7%, age-adjusted p=0.005). There was a trend suggest-
ing that cases had a higher frequency of CD57+CD4+
T cells than controls (median of 7.4% vs. 3.7%, age-
adjusted p=0.07). Cases also had a higher proportion of
CD28-/CD4+ cells (median of 9.1% vs. 4.8%, age adjusted
p=0.030) and CD28-/CD8+ cells (median of 60.5% vs.
51.3%, age adjusted p=0.044) vs. controls. Cases had a
lower proportion of CD27+/CD28+/CD45RA+ naive
CD8+ T cells vs. controls (median of 11.3% vs. 20.7%, age
adjusted p=0.022). There was a trend suggesting that
cases had a lower frequency of CD27+/CD28+/CD45RA
+ naive CD4+ cells vs. controls (median of 23.0% vs.
32.2%, age adjusted p=0.11).
Conclusion
The indolent KS observed among antiretroviral-treated
patients is associated with a higher frequency of immu-
nosenescent T cells, characterized by global immuno-
senescence markers and decreased numbers of naive
cells. These markers provide more evidence that KS
in these patients may be a consequence of enduring
HIV-associated T cell dysfunction and T cell immuno-
senescence. This association of immunosenescence in
otherwise well-treated HIV infection with an AIDS-
defining malignancy may provide important insights
into the role of immune dysfunction as a cause of pre-
mature morbidity commonly observed in the HIV+
cohorts. *Correspondence: patrick.unemori@ucsf.edu
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Table 1 Age and Markers of HIV Infection in HIV+ KS+ Cases and HIV+ KS- Controls
Number of
Subjects (N)
Median Age
(years)*
Median CD4 cell count
(cells/mm
3)
Median CD8 cell count
(cells/mm
3)
Median Viral Load (copies
RNA/mL)
HIV+ KS+
Cases 19 54* 701 933 <75
HIV+ KS-
Controls 47 43* 521 1200 <75
*p<0.05
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